We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

47 hedge funds and large institutions have $9.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $9.56M → $9.3M (-$263K)

8% less funds holding

Funds holding: 51 → 47 (-4)

60% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 15

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

75% less call options, than puts

Call options by funds: $236K | Put options by funds: $931K

Holders
47
Holders Change
-4
Holders Change %
-7.84%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
15
Closed
6
Calls
$236K
Puts
$931K
Net Calls
-$695K
Net Calls Change
-$106K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$77.7K
2
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$32.4K
3
BA
BlackRock Advisors
Delaware
+$15.1K
4
Group One Trading
Group One Trading
Illinois
+$14K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$7.55K

Top Sellers

1
ARTA
A.R.T. Advisors
New York
-$155K
2
GCP
GSA Capital Partners
United Kingdom
-$144K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$64.7K
4
Citadel Advisors
Citadel Advisors
Florida
-$52.9K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$48.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.61M – – –
BIT
2
BlackRock Institutional Trust
California
$1.22M – – –
B
3
Bailard
California
$1.03M – – –
KCM
4
Knoll Capital Management
Florida
$568K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$432K – – –
UCFA
6
United Capital Financial Advisors
Texas
$245K – – –
GBA
7
Garrison Bradford & Associates
New York
$241K -$14K -13 -6%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$228K +$7.55K +7 +4%
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$223K – – –
SIP
10
Stoneridge Investment Partners
Pennsylvania
$219K -$1.08K -1 -0.5%
BFA
11
BlackRock Fund Advisors
California
$213K – – –
LCM
12
Leisure Capital Management
California
$192K -$1.08K -1 -0.6%
Renaissance Technologies
13
Renaissance Technologies
New York
$143K +$77.7K +72 +131%
PNC Financial Services Group
14
PNC Financial Services Group
Pennsylvania
$137K -$8.63K -8 -6%
Neuberger Berman Group
15
Neuberger Berman Group
New York
$131K – – –
CCB
16
Cutter & Co Brokerage
Missouri
$130K -$4.32K -4 -3%
BIC
17
Beach Investment Counsel
Pennsylvania
$123K -$1.08K -1 -0.9%
Northern Trust
18
Northern Trust
Illinois
$118K -$41K -38 -27%
New York State Common Retirement Fund
19
New York State Common Retirement Fund
New York
$116K – – –
Bank of New York Mellon
20
Bank of New York Mellon
New York
$101K -$64.7K -60 -40%
HighTower Advisors
21
HighTower Advisors
Illinois
$86K – – –
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$78K – – –
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$76K – – –
Group One Trading
24
Group One Trading
Illinois
$68K +$14K +13 +28%
FNBT
25
FineMark National Bank & Trust
Florida
$64K – – –
1
2 3

NBSE Hedge Fund Activity: Q3 2016 in Review

47 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q3 2016, worth a combined $9.3M — down 2.7% from $9.56M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of NBSE and 2 opened new positions — a net loss of 4 holders — while 15 trimmed existing stakes and 6 added.

The largest buyer was Renaissance Technologies, adding an estimated $77.7K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $155K sold.

  • 47 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q3 2016, down from 51 in Q2 2016.
  • Funds reported $9.3M of NeuBase Therapeutics, Inc. Common Stock stock for Q3 2016, down 2.7% quarter-over-quarter.
  • 2 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q3 2016 and 6 closed out, a net change of -4 holders.
  • The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q3 2016 was Renaissance Technologies, an estimated $77.7K added.
  • The largest NeuBase Therapeutics, Inc. Common Stock seller in Q3 2016 was A.R.T. Advisors, an estimated $155K sold.

Based on aggregated 13F filings for Q3 2016.